The overarching goal of this study is to examine the acute vasoreactive response to both inhaled nitric oxide and inhaled epoprostenol across both traditionally and non-traditionally interrogated phenotypes in PH, and to further characterize the relationship of vasoreactivity to disease severity and PH phenotype.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Enrollment
115
Right heart catheterization with vasodilator testing with each arms' associated agent will be performed
Right heart catheterization with vasodilator testing with each arms' associated agent will be performed
Brigham and Women's Hospital
Boston, Massachusetts, United States
Change in mean pulmonary artery pressure
The primary outcome will be change in mean pulmonary artery pressure (mmHg) from baseline to after 5-minutes of inhaled vasodilator.
Time frame: Pre-pulmonary vasodilator testing measurements (baseline) will be compared to post-pulmonary vasodilator testing measurements during diagnostic right heart catheterization.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.